Related Experiment Video
Updated: Jun 24, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically
Kapil Gargh1, Eslam Al-Abadi2,3, Samantha Low4
1Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Women's and Children's Hospital NHS Foundation Trust, Steelhouse Lane, Birmingham, B4 6NH, West Midlands, UK.
Abstract:
The Paediatric Rheumatology International Trials Organisation (PRINTO) criteria for clinically inactive disease (CID) and their proposal for glucocorticoid tapering do not consider MRI findings, despite the growing use of MRI and development of reliable MRI scoring tools. We aim to evaluate how CID correlates with MRI scores and physician decision making. We retrospectively used the Juvenile Dermatomyositis Imaging Score (JIS) to score MRIs of all children with JDM over a 10-year period. Demographic, diagnosis, treatment and core set measures data were collected. Correlation between CID and JIS was assessed as well as correlation with the physician treatment decision. There were 25 patients with 59 follow-up episodes to analyse correlation between physician treatment decision and JIS; and 50 episodes for the CID category and JIS correlation. JIS was not significantly associated with the CID category but did correlate with the physician decision. No significant association was found between clinical decision and CID category. The JIS area under the ROC curve (AUC) was 0.80 (95% CI 0.62-0.99) with a score ≥ 8 to predict an escalation. JIS sensitivity and specificity were both 78% with accuracy of 78%, compared to only 67%, 46% and 49%, respectively, for the CID criteria. Clinical criteria alone are not sufficient to assess disease activity status. Clinical decision trends correlated to MRI findings but not PRINTO CID criteria. Multi centre prospective studies are needed to replicate our findings and establish how to best use MRI as a biomarker of disease activity.
Insights
The Juvenile Dermatomyositis Imaging Score (JIS) correlates with physician treatment decisions, unlike the PRINTO criteria for clinically inactive disease (CID). MRI findings are crucial for assessing JDM activity and guiding treatment escalation.
Area of Science:
- Pediatric Rheumatology
- Medical Imaging
- Disease Activity Assessment
Background:
- Current criteria for clinically inactive disease (CID) in Juvenile Dermatomyositis (JDM) do not incorporate Magnetic Resonance Imaging (MRI) findings.
- The use of MRI and standardized scoring tools for JDM is increasing.
- There is a need to evaluate the role of MRI in assessing JDM disease activity.
Purpose of the Study:
- To assess the correlation between MRI scores (using the Juvenile Dermatomyositis Imaging Score - JIS) and clinically inactive disease (CID) criteria.
- To evaluate the relationship between MRI findings and physician treatment decisions in JDM.
- To determine if MRI can better predict treatment escalation than current clinical criteria.
Main Methods:
- Retrospective analysis of MRIs from children with JDM over a 10-year period, scored using the JIS.
- Collection of demographic, diagnosis, treatment, and core set measures data.
- Statistical analysis to correlate JIS with CID categories and physician treatment decisions.
Main Results:
- The JIS was not significantly associated with the CID category but showed a correlation with physician treatment decisions.
- No significant association was found between clinical decisions and the CID category.
- The JIS demonstrated good predictive ability for treatment escalation (AUC 0.80), with 78% sensitivity, specificity, and accuracy, outperforming CID criteria.
Conclusions:
- Clinical criteria alone may be insufficient for accurately assessing JDM disease activity.
- Physician treatment decisions align with MRI findings, suggesting MRI's utility in clinical practice.
- Further multi-center prospective studies are required to validate these findings and establish MRI as a reliable biomarker for JDM activity.
Related Concept Videos
Magnetic Resonance Imaging
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Imaging Studies IV: Magnetic Resonance Imaging

